Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$11.46
EPS est.
$0.21
EPS surprise
+5278.54%
1-day move
+4.34%
—
Est. EPS
$1.57
Est. Rev
$464M
Impl. Move
±7.2%
Ascendis Pharma reported a significant earnings surprise with an EPS of $11.46, which drove the stock up by 4.34%. However, there was no revenue reported, and no guidance was provided. Investors may be reacting positively to the strong EPS figure, despite the lack of additional financial details.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $11.46 | N/A | +5278.54% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.